Indivior Pharmaceuticals (INDV) Research & Development (2024 - 2026)
Indivior Pharmaceuticals' Research & Development came in at $12 million for Q2 2026, down 42.9% from $21 million a year earlier and down 25.0% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Research & Development (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Indivior Pharmaceuticals reported Research & Development of $82 million, down 14.6% year-over-year; for FY2025, it was $97 million, down 9.3% from FY2024.
- Research & Development carries a four-year compound annual growth rate of 16.9% (FY2021 to FY2025).
- Going back by year, Research & Development was $107 million in FY2024 (-7.8%), $116 million in FY2023 (+56.8%), $74 million in FY2022 (+42.3%) and $52 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Research & Development in data going back to Q1 2024.
- Year-over-year, Research & Development has declined for three consecutive quarters, with an average decline of 15.5% over the last six quarters.
- Business Quant data shows INDV's Research & Development at $16 million (Q1 2026), $21 million (Q4 2025) and $33 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.10 Bn | 1,100.69 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.67 Bn | 534.20 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 504.61 Bn | 477.72 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 368.03 Bn | 322.41 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.24 Bn | 262.23 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.77 Bn | 235.46 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.62 Bn | 164.81 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Indivior Pharmaceuticals | 4.17 Bn | 3.14 Bn | 294.00 Mn | 12.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.00 Mn |
| Mar 31, 2026 | 16.00 Mn |
| Dec 31, 2025 | 21.00 Mn |
| Sep 30, 2025 | 33.00 Mn |
| Jun 30, 2025 | 21.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 28.00 Mn |
API Access
Indivior Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();